Cargando…
Alendronate Effect on the Prevention of Bone loss in Early Stages of Ankylosing Spondylitis: A Randomized, Double-Blind, Placebo-Controlled Pilot Study
BACKGROUND: Ankylosing spondylitis (AS) is an inflammatory rheumatic disease that leads to a progressive ankylosis of vertebras and ossification of paravertebral ligaments. Bone loss and osteoporosis are amongst the important complications of AS, treatment of which is a challenging issue. OBJECTIVES...
Autores principales: | Khabbazi, Alireza, Noshad, Hamid, Gafarzadeh, Sevil, Hajialiloo, Mehrzad, Kolahi, Susan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Kowsar
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4102986/ https://www.ncbi.nlm.nih.gov/pubmed/25068053 http://dx.doi.org/10.5812/ircmj.18022 |
Ejemplares similares
-
Ankylosing Spondylitis in Iran; Late Diagnosis and Its Causes
por: Hajialilo, Mehrzad, et al.
Publicado: (2014) -
A retrospective study of alendronate for the treatment of ankylosing spondylitis
por: Li, Gang, et al.
Publicado: (2018) -
Mental Health Status of Women With Rheumatoid Arthritis in Iran
por: Kolahi, Sousan, et al.
Publicado: (2014) -
Tofacitinib for the treatment of ankylosing spondylitis: a phase III, randomised, double-blind, placebo-controlled study
por: Deodhar, Atul, et al.
Publicado: (2021) -
Efficacy of Nigella sativa seeds oil in patients with Behcet’s disease: a double-blind randomized controlled trial
por: Kavandi, Hadiseh, et al.
Publicado: (2018)